Scientific Publications and Presentations Sample Clauses

Scientific Publications and Presentations. Tocagen will strive to publish the results of the Brain Cancer Therapies Program related activities and research in a peer-reviewed scientific journal and present its findings at scientific conferences as soon as possible during or after the Grant Period in a manner that will advance scientific knowledge; such publications or presentations being consistent with conservative practices of commercial pharmaceutical development entities to protect its intellectual property and market its products. Nothing in this agreement shall require Tocagen to publish confidential business information, incomplete information, or information not regularly publically disclosed by a commercial pharmaceutical development company.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Scientific Publications and Presentations. The Parties acknowledge that scientific publications must be strictly monitored to prevent any adverse effect from premature publication of Research Results. Subject to Section 8.2.1, a Party shall not publish, present or otherwise disclose any material related to the combinations in the Licensed Combination Field or Collaboration Combination Field without the prior written consent of the other Party. Notwithstanding the foregoing, CombinatoRx and Fovea may publish Subsequent CombinatoRx Collaboration Combination IP and Subsequent Fovea Collaboration Combination IP, respectively, without the consent of the other Party.
Sample 1Sample 2
Scientific Publications and Presentations. To achieve the strongest impact possible among the scientific community, and to secure international prominence, S4CE has and will continue to publish review papers where the multi-disciplinary nature of the research supported by the consortium will be showcased. Each of our scientific community has a number of dedicated journals. S4CE review papers will cross these traditional boundaries: S4CE will publish in cement and concrete -dedicated journals and will showcase the importance of earth scientists and engineering contributions to our society. The journals in which S4CE will publish the reviews are: Earth-Science Reviews, the Journal of Petroleum Science and Engineering, and the Journal of Physical Chemistry Letters, Nature – Scientific Reports, the National Academies Press, Science Direct – Procedia, Science Direct - Materials and Design, International Journal of Coal Geology, Microporous and Mesoporous Materials, Nature Communications, International Journal of Greenhouse Gas Control, Bulletin of the Seismological Society of America, Physical Chemistry Chemical Physics. Based on the productivity of team members, S4CE expects at least 15 peer-reviewed journal articles per year. The articles will target academics, oil and gas industries and consultancy groups. S4CE will publish in Open Access publication platforms such as ScienceOpen. Each new publication has been advertised on Twitter and on the newsletter. S4CE partners will present their publications at conferences and congresses. When relevant, they will create posters, which will be showcased on the website as well.
Sample 1
Scientific Publications and Presentations. [*] Confidential treatment requested.
Sample 1
Scientific Publications and Presentations. The JSC will establish a publication policy ("Publication Policy") regarding the results of the Product Development Program under this Agreement. Neither Party shall publish or present such results in a manner that does not comply with such Publication Policy. At a minimum, the Publication Policy will require each Party to provide sufficient time for the other Party to review any proposed manuscripts, abstracts, posters or other materials proposed for publication or presentation. Upon request, each Party agrees to delay any such submission for a period sufficient to permit adequate steps to be taken to prepare and file a patent application for any patentable subject matter referred to therein. In addition, each Party agrees to delete from any such proposed submission any Confidential Information of the other Party upon its request.
Sample 1
Scientific Publications and Presentations. Each Party shall have the right to review and comment on any paper, oral presentations and abstracts, proposed for publication by the other Party or, subject to the publication policies of applicable academic institutions, Third Parties in respect of which such Party can exert control over publications which utilizes Clinical Data or other data or results generated from any studies performed hereunder or otherwise in respect of the Covered Products or that includes any Confidential Information of the other Party. Before any such paper is submitted for publication, the Party proposing publication shall deliver a complete copy to the other Party at least forty-five (45) days prior to submitting the paper to a publisher. The receiving Party shall review any such paper and give its comments to the publishing Party within thirty (30) days of the delivery of such paper to the receiving Party. With respect to oral presentation materials and abstracts, the Parties shall make reasonable efforts to expedite review of such materials and abstracts, and shall return such items as soon as practicable to the publishing Party with appropriate comments, if any, in an expedited manner, but in no event later than ten (10) days (or such shorter period as the Parties may agree in good faith in exigent circumstances) from the date of delivery to the receiving Party. The publishing Party shall comply with the other Party’s request to delete references to such other Party or such Party’s Confidential Information in any such paper, oral presentation or abstract and, if the reviewing Party identifies patentable inventions, shall withhold publication of same for an additional sixty (60) days in order to permit the Parties to obtain patent protection in accordance with the terms of this Agreement, if either of the Parties deem it necessary. Notwithstanding the foregoing, either Party may make an oral presentation that was previously approved by the other Party without again submitting such presentation for review by the other Party.
Sample 1
Scientific Publications and Presentations. Licensee recognizes that Licensor is a public non-profit, research and educational institution and, as such, conducts scientific research and medical education. Licensor's mission is to perform research and to educate medical scientists with the goal of improving current methods of life-saving critical care. As such, Licensee further recognizes that Licensor's primary method of achieving such progress is by timely presentations, publications and other means of disseminating scientific knowledge in the public interest. Licensor may publicly disseminate such information except to the extent that such dissemination would directly compromise the commercialization of Sensors or Instruments by Licensee or such dissemination discloses patentable or other information proprietary to Licensee. The rights of presentation and publication of scientific discoveries made during the term of this Agreement are subject to Licensee's prior approval, which will not be unreasonably withheld. Licensor will provide pre-publication documentation for review and comment by Licensee. Such review will be completed within ten (10) working days or extensions not to exceed an additional five (5) working days at the request of Licensee.
Sample 1
AutoNDA by SimpleDocs
Scientific Publications and Presentations 
Sample 1

Related to Scientific Publications and Presentations

  • Publications and Presentations For purposes of this Agreement, “Scientific Publication” means any scientific publication or medical communication regarding Study results in any form that is intended for disclosure to third parties, including, without limitation, manuscripts, abstracts, posters, slides or other materials used for presentations. 10. Publikace a prezentace. „Vědecká publikace“ znamená pro účely této Smlouvy každou vědeckou publikaci nebo lékařské sdělení týkající se výsledků Studie, v libovolné formě určené ke sdělení třetím stranám, zejména rukopisy, abstrakty, postery, snímky nebo jiné materiály používané pro prezentace.

  • Scientific Publications During the Research Program Term, neither Party shall first publish or first present in a public forum the scientific or technical results of any activity performed pursuant to this Agreement without the opportunity for prior review and comment by the other Party. Each Party agrees to provide the other Party with the opportunity to review any proposed abstract, manuscript or scientific presentation (including any verbal presentation) that relates to its activities performed pursuant to this Agreement during the Research Program Term, at least [**] days prior to its intended submission for publication and agrees, upon request, not to submit any such abstract or manuscript for publication until the other Party is given a reasonable period of time up to [**] to secure patent protection for any material in such publication that it believes to be patentable. Both Parties understand that a reasonable commercial strategy may require delay of publication of information or filing of patent applications first with respect to activities performed or results obtained pursuant to this Agreement during the Research Program Term, or not to publish at all if necessary to preserve trade secrets. The Parties agree to review and decide whether to delay publication of such information to permit filing of patent applications. Neither Party shall have the right to publish or present any Confidential Information of the other Party, except as provided in Section 9.2. After the Research Program Term, each Party and its Affiliates may publish or present results, data or scientific findings of any of their activities without the prior review of the other Party, provided that such publication or presentation does not disclose any of the other Party’s Confidential Information. Nothing contained in this Section 9.3 shall prohibit the inclusion of information necessary for a patent application; provided that the non-filing Party is given a reasonable opportunity to review the information to be included prior to submission of such patent application in accordance with Section 8.2. Nothing contained in this Section 9.3 shall prohibit either Party from disclosing the results, data or scientific findings of any activity performed by the other Party or its Affiliates pursuant to this Agreement without prior review and prior written consent of the other Party, where required, as reasonably determined by the disclosing Party’s legal counsel, by applicable law; provided that if a Party is required by law to make any such disclosure, to the extent it may legally do so, it will give reasonable advance notice to the other Party of such disclosure and will use its reasonable efforts to secure confidential treatment of such information prior to its disclosure (whether through protective orders or otherwise).

  • Publications and Public Statements I will obtain the Company’s written approval before publishing or submitting for publication any material that relates to my work at the Company and/or incorporates any Proprietary Information. To ensure that the Company delivers a consistent message about its products, services and operations to the public, and further in recognition that even positive statements may have a detrimental effect on the Company in certain securities transactions and other contexts, any statement about the Company which I create, publish or post during my period of employment and for six (6) months thereafter, on any media accessible by the public, including but not limited to electronic bulletin boards and Internet-based chat rooms, must first be reviewed and approved by an officer of the Company before it is released in the public domain.

  • Publications All published material and written reports submitted under the Contract must be originally developed material unless otherwise specifically provided in the Contract. When material not originally developed is included in a report in any form, the source shall be identified.

  • FINANCIAL INFORMATION AND NOTICES Until all the Obligations have been finally and indefeasibly paid and satisfied in full and the Commitments terminated, unless consent has been obtained in the manner set forth in Section 12.9 hereof, the Borrower will furnish or cause to be furnished to the Administrative Agent and each Lender at its address set forth in Schedule 1, or such other office as may be designated by the Agent or the applicable Lender from time to time:

  • Information/Cooperation Executive shall, upon reasonable notice, furnish such information and assistance to the Bank as may be reasonably required by the Bank, in connection with any litigation in which it or any of its subsidiaries or affiliates is, or may become, a party; provided, however, that Executive shall not be required to provide information or assistance with respect to any litigation between Executive and the Bank or any other subsidiaries or affiliates.

  • Confidentiality and Publication Subject to the remaining provisions of this clause 8, each Party will treat all Confidential Information of any other Party as confidential and will not, without the consent of the other relevant Party, disclose or permit the same either to be disclosed to third parties or to be used, except solely as contemplated by this Agreement. Each Party must use all reasonable endeavours to ensure that its representatives comply with the obligations of confidentiality imposed upon it under this clause 8 as if those representatives were bound in the same way. Each Party must advise each other Party as soon as practicably possible of any breach of any confidentiality obligations under this Agreement of which it becomes aware. A Party may disclose Confidential Information if required to do so by law or to its professional advisers, subject to the relevant adviser being bound by similar obligations of confidentiality, or if necessary, entering into an appropriate confidentiality undertaking. A Party may publish the Project IP, subject to it complying with the following: prior to any publication, the Party must provide the other Party with full details of the Project IP it proposes to publish and the nature of the publication; and the other Party must notify the first Party whether permission to publish has been granted or refused within 30 days of the request (or such other period as may be set out at Item 7 of the Schedule) (Period); and if the other Party fails to notify the first Party of its decision under clause 8.5(b) within the Period shall be deemed to have consented to the proposed publication by the first Party; and any other Party may only refuse a request to publish if, in that other Party’s reasonable opinion, the publication is likely to jeopardise: the protection of Project IP (as applicable) under any statute of monopoly; or the successful commercialisation of the Project IP by the Party with such rights, or

  • Non-Publication The parties mutually agree not to disclose publicly the terms of this Agreement except to the extent that disclosure is mandated by applicable law or regulation or to their respective advisors (e.g., attorneys, accountants).

  • Confidentiality Publication (a) Background Intellectual Property and Project Intellectual Property of a party, as well as other proprietary or confidential information of a party, disclosed by that party to the other in connection with this STTR project shall be received and held in confidence by the receiving party and, except with the consent of the disclosing party or as permitted under this Agreement, neither used by the receiving party nor disclosed by the receiving party to others, provided that the receiving party has notice that such information is regarded by the disclosing party as proprietary or confidential. However, these confidentiality obligations shall not apply to use or disclosure by the receiving party after such information is or becomes known to the public without breach of this provision or is or becomes known to the receiving party from a source reasonably believed to be independent of the disclosing party or is developed by or for the receiving party independently of its disclosure by the disclosing party.

  • Access to Financial Information Buyer’s representatives shall have access to, and Seller and its Affiliates shall cooperate with Buyer and furnish upon request, all financial and other information relating to the Hotel’s operations to the extent necessary to enable Buyer’s representatives to prepare audited financial statements in conformity with Regulation S-X of the Securities and Exchange Commission (the “SEC”) and other applicable rules and regulations of the SEC and to enable them to prepare a registration statement, report or disclosure statement for filing with the SEC on behalf of Buyer or its Affiliates, whether before or after Closing and regardless of whether such information is included in the Records to be transferred to Buyer hereunder. Seller shall also provide to Buyer’s representative a signed representation letter in form and substance reasonably acceptable to Seller sufficient to enable an independent public accountant to render an opinion on the financial statements related to the Hotel. Buyer will reimburse Seller for costs reasonably incurred by Seller to comply with the requirements of the preceding sentence to the extent that Seller is required to incur costs not in the ordinary course of business for third parties to provide such representation letters. The provisions of this Section shall survive Closing or termination of this Contract.

Time is Money Join Law Insider Premium to draft better contracts faster.